COVID-19 Infection: Concise Review Based on the Immunological Perspective

References

• Ahmed SF, Quadeer AA, McKay MR. 2020. Preliminary identification of potential vaccine targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV immunological studies. Viruses. 12(3):254.
   PubMed Web of Science ®Google Scholar
• Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, Tao Q, Sun Z, Xia L. 2020. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 200642. doi:https://doi.org/10.1148/radiol.2020200642
   PubMed Web of Science ®Google Scholar
• Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. 2020. The proximal origin of SARS-CoV-2. Nat Med. 26(4):450–52.
   PubMed Web of Science ®Google Scholar
• André P, Denis C, Soulas C, Bourbon-Caillet C, Lopez J, Arnoux T, Bléry M, Bonnafous C, Gauthier L, Morel A, et al. 2018. Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells. Cell. 175(7):1731–1743.e13.
   PubMed Web of Science ®Google Scholar
• Arabi YM, Mandourah Y, Al-Hameed F, Sindi AA, Almekhlafi GA, Hussein MA, Jose J, Pinto R, Al-Omari A, Kharaba A, et al. 2018. Corticosteroid therapy for critically ill patients with middle east respiratory syndrome. Am J Respir Crit Care Med. 197(6):757–67.
   PubMed Web of Science ®Google Scholar
• Arruvito L, Payaslián F, Baz P, Podhorzer A, Billordo A, Pandolfi J, Semeniuk G, Arribalzaga E, Fainboim L. 2014. Identification and clinical relevance of naturally occurring human CD8 + HLA-DR + regulatory T cells. J Immunol. 193(9):4469–76.
   PubMed Web of Science ®Google Scholar
• Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, Freeman GJ, Ahmed R. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 439(7077):682–87.
   PubMed Web of Science ®Google Scholar
• Batisse D, Benech N, Botelho-Nevers E, Bouiller K, Collarino R, Conrad A, Gallay L, Goehringer F, Gousseff M, Joseph DC, et al. 2020. Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound? J Infect. doi:https://doi.org/10.1016/j.jinf.2020.06.073
   Google Scholar
• Bezerra RDS, Valença IN, Cassia Ruy P, Ximenez JPB, Silva Júnior WA, Covas DT, Kashima S, Slavov SN. 2020. The novel coronavirus SARS‐CoV‐2: from a zoonotic infection to coronavirus disease‐19 (COVID19). J Med Virol Jmv. 26072. doi:https://doi.org/10.1002/jmv.26072
   Google Scholar
• Bordi L, Nicastri E, Scorzolini L, Di Caro A, Capobianchi MR, Castilletti C, Lalle E 2020. Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020. Eurosurveillance. 25(8). doi:https://doi.org/10.2807/1560-7917.ES.2020.25.8.2000170
   Google Scholar
• Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, et al. 2020. A trial of lopinavir–ritonavir in adults hospitalized with severe covid-19. N Engl J Med. 382(19):1787–99.
   PubMed Web of Science ®Google Scholar
• Carter LJ, Garner LV, Smoot JW, Li Y, Zhou Q, Saveson CJ, Sasso JM, Gregg AC, Soares DJ, Beskid TR, et al. 2020. Assay techniques and test development for COVID-19 diagnosis. ACS Cent Sci. 6(5):591–605.
   PubMed Web of Science ®Google Scholar
• Chafekar A, Fielding BC. 2018. MERS-CoV: understanding the latest human coronavirus threat. Viruses. 10:93.
   PubMed Web of Science ®Google Scholar
• Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK, Perlman S. 2016. Dysregulated Type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe. 19(2):181–93.
   PubMed Web of Science ®Google Scholar
• Channappanavar R, Perlman S. 2017. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 39(5):529–39.
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, et al. 2020. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 395(10223):507–13.
   PubMed Web of Science ®Google Scholar
• Cheng ZJ, Shan J. 2020. 2019 Novel coronavirus: where we are and what we know. Infection. 48(2):155–63.
   PubMed Web of Science ®Google Scholar
• Chu DKW, Pan Y, Cheng SMS, Hui KPY, Krishnan P, Liu Y, Ng DYM, Wan CKC, Yang P, Wang Q, et al. 2020. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem. 66(4):549–55.
   PubMed Web of Science ®Google Scholar
• Chu H, Zhou J, Wong BH-Y, Cun L, Chan JF-W, Cheng Z-S, Yang D, Wang D, Lee AC-Y, Li C, et al. 2016. Middle east respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J Infect Dis. 213(6):904–14.
   PubMed Web of Science ®Google Scholar
• Coccia EM, Severa M, Giacomini E, Monneron D, Remoli ME, Julkunen I, Cella M, Lande R, Uzé G. 2004. Viral infection and Toll-like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol. 34(3):796–805.
   PubMed Web of Science ®Google Scholar
• Cohen J. 2020. New coronavirus threat galvanizes scientists. Science (80-). 367(6477):492–93.
   PubMed Web of Science ®Google Scholar
• D’Elia RV, Harrison K, Oyston PC, Lukaszewski RA, Clark GC. 2013. Targeting the “Cytokine Storm” for therapeutic benefit. Clin Vaccine Immunol. 20(3):319–27.
   PubMedGoogle Scholar
• Dai W, Zhang H-W, Yu J, Xu H, Chen H, Luo S, Zhang H, Liang L, Wu X, Lei Y, et al. 2020. CT imaging and differential diagnosis of COVID-19. Can Assoc Radiol J. 71(2):195–200.
   PubMed Web of Science ®Google Scholar
• Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, Chen L, Li M, Liu Y, Wang G, et al. 2020. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol. 11. doi:https://doi.org/10.3389/fimmu.2020.00827
   Web of Science ®Google Scholar
• Drosten C, Günther S, Preiser W, van der Werf S, Brodt H-R, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RAM, et al. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 348(20):1967–76.
   PubMed Web of Science ®Google Scholar
• Du L, He Y, Zhou Y, Liu S, Zheng B-J, Jiang S. 2009. The spike protein of SARS-CoV — a target for vaccine and therapeutic development. Nat Rev Microbiol. 7(3):226–36.
   PubMed Web of Science ®Google Scholar
• Du L, Jiang S. 2015. Middle East respiratory syndrome: current status and future prospects for vaccine development. Expert Opin Biol Ther. 15(11):1647–51.
   PubMed Web of Science ®Google Scholar
• Dunning J, Blankley S, Hoang LT, Cox M, Graham CM, James PL, Bloom CI, Chaussabel D, Banchereau J, Brett SJ, et al. 2018. Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza. Nat Immunol. 19(6):625–35.
   PubMed Web of Science ®Google Scholar
• Frieman M, Heise M, Baric R. 2008. SARS coronavirus and innate immunity. Virus Res. 133(1):101–12.
   PubMed Web of Science ®Google Scholar
• Gabriella DM, Cristina S, Concetta R, Francesco R, Annalisa C. 2020. SARS-Cov-2 infection: response of human immune system and possible implications for the rapid test and treatment. Int Immunopharmacol. 84:106519.
   PubMed Web of Science ®Google Scholar
• Graham RL, Donaldson EF, Baric RS. 2013. A decade after SARS: strategies for controlling emerging coronaviruses. Nat Rev Microbiol. 11(12):836–48.
   PubMed Web of Science ®Google Scholar
• Guo L, Wei D, Zhang X, Wu Y, Li Q, Zhou M, Qu J. 2019. Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA Score. Front Microbiol. 10. doi:https://doi.org/10.3389/fmicb.2019.02752
   Google Scholar
• Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z. 2020. cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 5(7):811.
   PubMed Web of Science ®Google Scholar
• Haanen JB, Cerundolo V. 2018. NKG2A, a new kid on the immune checkpoint block. Cell. 175(7):1720–22.
   PubMed Web of Science ®Google Scholar
• Hajeer A, Balkhy H, Johani S, Yousef M, Arabi Y. 2016. Association of human leukocyte antigen class II alleles with severe Middle East respiratory syndrome-coronavirus infection. Ann Thorac Med. 11(3):211.
   PubMed Web of Science ®Google Scholar
• Hu Y, Li W, Gao T, Cui Y, Jin Y, Li P, Ma Q, Liu X, Cao C 2017. The severe acute respiratory syndrome coronavirus nucleocapsid inhibits type i interferon production by interfering with TRIM25-mediated RIG-I ubiquitination. J Virol. 91(8). doi:https://doi.org/10.1128/JVI.02143-16
   Google Scholar
• Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Huang K-J, Su I-J, Theron M, Wu Y-C, Lai S-K, Liu -C-C, Lei H-Y. 2005. An interferon-?-related cytokine storm in SARS patients. J Med Virol. 75(2):185–94.
   PubMed Web of Science ®Google Scholar
• Jauregui AR, Savalia D, Lowry VK, Farrell CM, Wathelet MG. 2013. Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling. PLoS One. 8(4):e62416.
   PubMed Web of Science ®Google Scholar
• Jin Y-H, Cai L, Cheng Z-S, Cheng H, Deng T, Fan Y-P, Fang C, Huang D, Huang L-Q, Huang Q, et al. 2020. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 7:4.
   PubMed Web of Science ®Google Scholar
• Keicho N, Itoyama S, Kashiwase K, Phi NC, Long HT, Ha LD, Ban V, Van H, Hang BK, Le NT, et al. 2009. Association of human leukocyte antigen class II alleles with severe acute respiratory syndrome in the Vietnamese population. Hum Immunol. 70(7):527–31.
   PubMed Web of Science ®Google Scholar
• Knoops K, Kikkert M, Worm SHE, van Den, Zevenhoven-dobbe JC, van der Meer Y, Koster AJ, Mommaas AM, Snijder EJ. 2008. SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol. 6(9):e226.
   PubMed Web of Science ®Google Scholar
• Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP. 2003. IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol. 4(1):69–77.
   PubMed Web of Science ®Google Scholar
• Lan L, Xu D, Ye G, Xia C, Wang S, Li Y, Xu H. 2020. Positive RT-PCR test results in patients recovered from COVID-19. JAMA. 323(15):1502.
   PubMed Web of Science ®Google Scholar
• Lauterbach H, Bathke B, Gilles S, Traidl-Hoffmann C, Luber CA, Fejer G, Freudenberg MA, Davey GM, Vremec D, Kallies A, et al. 2010. Mouse CD8α+ DCs and human BDCA3+ DCs are major producers of IFN-λ in response to poly IC. J Exp Med. 207(12):2703–17.
   PubMed Web of Science ®Google Scholar
• Law HKW, Cheung CY, Ng HY, Sia SF, Chan YO, Luk W, Nicholls JM, Peiris JSM, Lau YL. 2005. Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells. Blood. 106(7):2366–74.
   PubMed Web of Science ®Google Scholar
• Li CK, Wu H, Yan H, Ma S, Wang L, Zhang M, Tang X, Temperton NJ, Weiss RA, Brenchley JM, et al. 2008. T cell responses to whole SARS coronavirus in humans. J Immunol. 181(8):5490–500.
   PubMed Web of Science ®Google Scholar
• Li F. 2016. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol. 3:237–61.
   PubMed Web of Science ®Google Scholar
• Li F, Wei H, Wei H, Gao Y, Xu L, Yin W, Sun R, Tian Z. 2013. Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice. Gastroenterology. 144(2):392–401.
   PubMed Web of Science ®Google Scholar
• Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, Pan P, Wang W, Hu D, Liu X, et al. 2020a. Coronavirus infections and immune responses. J Med Virol. 92(4):424–32.
   PubMed Web of Science ®Google Scholar
• Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, et al. 2020b. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 382(13):1199–207.
   PubMed Web of Science ®Google Scholar
• Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, et al. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 426(6965):450–54.
   PubMed Web of Science ®Google Scholar
• Ling Y, Xu S-B, Lin Y-X, Tian D, Zhu Z-Q, Dai F-H, Wu F, Song Z-G, Huang W, Chen J, et al. 2020. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl). 133(9):1039–43.
   PubMed Web of Science ®Google Scholar
• Liu J, Wu P, Gao F, Qi J, Kawana-Tachikawa A, Xie J, Vavricka CJ, Iwamoto A, Li T, Gao GF. 2010. Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic t-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein. J Virol. 84(22):11849–57.
   PubMed Web of Science ®Google Scholar
• Liu WJ, Zhao M, Liu K, Xu K, Wong G, Tan W, Gao GF. 2017. T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV. Antiviral Res. 137:82–92.
   PubMed Web of Science ®Google Scholar
• Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, et al. 2020. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 395(10224):565–74.
   PubMed Web of Science ®Google Scholar
• Masters PS. 2006. The molecular biology of coronaviruses. In: Advances in virus research, Vol. 66. Academic Press. p. 193–292.
   Google Scholar
• McBride R, van Zyl M, Fielding B. 2014. The coronavirus nucleocapsid is a multifunctional protein. Viruses. 6(8):2991–3018.
   PubMed Web of Science ®Google Scholar
• McLane LM, Abdel-Hakeem MS, Wherry EJ. 2019. CD8 T cell exhaustion during chronic viral infection and cancer. Annu Rev Immunol. 37(1):457–95.
   PubMed Web of Science ®Google Scholar
• Mescher MF, Curtsinger JM, Agarwal P, Casey KA, Gerner M, Hammerbeck CD, Popescu F, Xiao Z. 2006. Signals required for programming effector and memory development by CD8+ T cells. Immunol Rev. 211(1):81–92.
   PubMed Web of Science ®Google Scholar
• Millán-Oñate J, Rodriguez-Morales AJ, Camacho-Moreno G, Mendoza-Ramírez H, Rodríguez-Sabogal IA, Álvarez-Moreno C. 2020. A new emerging zoonotic virus of concern: the 2019 novel Coronavirus (COVID-19). Infectio. 24(3):187.
   Google Scholar
• Mordstein M, Neugebauer E, Ditt V, Jessen B, Rieger T, Falcone V, Sorgeloos F, Ehl S, Mayer D, Kochs G, et al. 2010. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol. 84(11):5670–77.
   PubMed Web of Science ®Google Scholar
• Nelemans T, Kikkert M. 2019. Viral innate immune evasion and the pathogenesis of emerging RNA virus infections. Viruses. 11(10):961.
   PubMed Web of Science ®Google Scholar
• Niemeyer D, Zillinger T, Muth D, Zielecki F, Horvath G, Suliman T, Barchet W, Weber F, Drosten C, Muller MA. 2013. Middle east respiratory syndrome coronavirus accessory protein 4a is a type i interferon antagonist. J Virol. 87(22):12489–95.
   PubMed Web of Science ®Google Scholar
• Okabayashi T, Kojima T, Masaki T, Yokota S, Imaizumi T, Tsutsumi H, Himi T, Fujii N, Sawada N. 2011. Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells. Virus Res. 160(1–2):360–66.
   PubMed Web of Science ®Google Scholar
• Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, De Leacy RA, Shigematsu T, Ladner TR, Yaeger KA, et al. 2020. Large-vessel stroke as a presenting feature of covid-19 in the young. N Engl J Med. 382(20):e60.
   PubMed Web of Science ®Google Scholar
• Park M, Thwaites RS, Openshaw PJM. 2020. COVID‐19: lessons from SARS and MERS. Eur J Immunol. 50(3):308–11.
   Web of Science ®Google Scholar
• Pormohammad A, Ghorbani S, Khatami A, Farzi R, Baradaran B, Turner DL, Turner RJ, Bahr NC, Idrovo J. 2020. Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis. Rev Med Virol. e2112. doi:https://doi.org/10.1002/rmv.2112
   Google Scholar
• Prajapat M, Sarma P, Shekhar N, Avti P, Sinha S, Kaur H, Kumar S, Bhattacharyya A, Kumar H, Bansal S, et al. 2020. Drug for corona virus: A systematic review. Indian J Pharmacol. 52(1):56.
   PubMed Web of Science ®Google Scholar
• Prompetchara E, Ketloy C, Palaga T. 2020. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pacific J Allergy Immunol. 38:1–9.
   PubMed Web of Science ®Google Scholar
• Raj VS, Mou H, Smits SL, Dekkers DHW, Müller MA, Dijkman R, Muth D, Demmers JAA, Zaki A, Fouchier RAM, et al. 2013. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 495(7440):251–54.
   PubMed Web of Science ®Google Scholar
• Ray A, Dittel BN. 2015. Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis. Immunology. 146(3):359–68.
   PubMed Web of Science ®Google Scholar
• Roper RL, Rehm KE. 2009. SARS vaccines: where are we?. Expert Rev Vacc. 8:887–98.
   PubMed Web of Science ®Google Scholar
• Russell CD, Millar JE, Baillie JK. 2020. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 395(10223):473–75.
   PubMed Web of Science ®Google Scholar
• Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N, Ke R. 2020. High contagiousness and rapid spread of severe acute respiratory syndrome Coronavirus 2. Emerging Infectious Diseases. 26(7):1470–77. https://ind01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fdoi.org%2F10.3201%2Feid2607.200282&data=02%7C01%7Csathyan.dhanasekaran%40integra.co.in%7Ca61cc99bb6194ceccbb008d85f9ee080%7C70e2bc386b4b43a19821a49c0a744f3d%7C0%7C0%7C637364483269538189&sdata=C7N5NW2Z%2BI2J53LukO2%2BGcvCHCaG6bWM8%2FuvD0guqf8%3D&reserved=0
   Google Scholar
• Schoeman D, Fielding BC. 2019. Coronavirus envelope protein: current knowledge. Virol J. 16:69.
   PubMed Web of Science ®Google Scholar
• Seguin A, Galicier L, Boutboul D, Lemiale V, Azoulay E. 2016. Pulmonary involvement in patients with hemophagocytic lymphohistiocytosis. Chest. 149(5):1294–301.
   PubMed Web of Science ®Google Scholar
• Sen S, Anand KB, Karade S, Gupta RM. 2020. Coronaviruses: origin and evolution. Med J Armed Forces India. 76:136–41.
   PubMedGoogle Scholar
• Sethuraman N, Jeremiah SS, Ryo A. 2020. Interpreting diagnostic tests for SARS-CoV-2. JAMA. 323(22):2249.
   PubMed Web of Science ®Google Scholar
• Shen K, Yang Y, Wang T, Zhao D, Jiang Y, Jin R, Zheng Y, Xu B, Xie Z, Lin L, et al. 2020. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement. World J Pediatr. doi:https://doi.org/10.1007/s12519-020-00343-7
   Google Scholar
• Shi C-S, Qi H-Y, Boularan C, Huang -N-N, Abu-Asab M, Shelhamer JH, Kehrl JH. 2014. SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome. J Immunol. 193(6):3080–89.
   PubMed Web of Science ®Google Scholar
• Spann KM, Baturcam E, Schagen J, Jones C, Straub CP, Preston FM, Chen L, Phipps S, Sly PD, Fantino E. 2014. Viral and host factors determine innate immune responses in airway epithelial cells from children with wheeze and atopy. Thorax. 69(10):918–25.
   PubMed Web of Science ®Google Scholar
• Stebbing J, Phelan A, Griffin I, Tucker C, Oechsle O, Smith D, Richardson P. 2020. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis. 20(4):400–02.
   PubMed Web of Science ®Google Scholar
• Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, Talavera-López C, Maatz H, Reichart D, Sampaziotis F, et al. 2020. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 26(5):681–87.
   PubMed Web of Science ®Google Scholar
• Tetro JA. 2020. Is COVID-19 receiving ADE from other coronaviruses? Microbes Infect. 22(2):72–73.
   PubMed Web of Science ®Google Scholar
• Tian X, Li C, Huang A, Xia S, Lu S, Shi Z, Lu L, Jiang S, Yang Z, Wu Y, et al. 2020. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg Microbes Infect. 9(1):382–85.
   PubMed Web of Science ®Google Scholar
• Tiwari R, Dhama K, Sharun K, Iqbal Yatoo M, Malik YS, Singh R, Michalak I, Sah R, Bonilla-Aldana DK, Rodriguez-Morales AJ. 2020. COVID-19: animals, veterinary and zoonotic links. Vet Q. 40(1):169–82.
   PubMed Web of Science ®Google Scholar
• Totura AL, Whitmore A, Agnihothram S, Schäfer A, Katze MG, Heise MT, Baric RS 2015. Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection. MBio. 6(3). doi:https://doi.org/10.1128/mBio.00638-15
   Google Scholar
• Tseng C-TK, Perrone LA, Zhu H, Makino S, Peters CJ. 2005. Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection. J Immunol. 174:7977–85.
   PubMed Web of Science ®Google Scholar
• Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VYC, Chen H, Mubareka S, Gubbay JB, Chan WCW. 2020. Diagnosing COVID-19: the disease and tools for detection. ACS Nano. 14(4):3822–35.
   PubMed Web of Science ®Google Scholar
• Ulrich H, Pillat MM. 2020. CD147 as a target for COVID-19 treatment: suggested effects of azithromycin and stem cell engagement. Stem Cell Rev Reports. 16(3):434–40.
   PubMed Web of Science ®Google Scholar
• Venkatagopalan P, Daskalova SM, Lopez LA, Dolezal KA, Hogue BG. 2015. Coronavirus envelope (E) protein remains at the site of assembly. Virology. 478:75–85.
   PubMed Web of Science ®Google Scholar
• Vittori A, Lerman J, Cascella M, Gomez-Morad AD, Marchetti G, Marinangeli F, Picardo SG. 2020. COVID-19 pandemic acute respiratory distress syndrome survivors: pain after the storm? Anesth. Analg. 131(1):117–19.
   Google Scholar
• Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, et al. 2020a. clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 323(11):1061.
   PubMed Web of Science ®Google Scholar
• Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. 2020b. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30(3):269–71.
   PubMed Web of Science ®Google Scholar
• Wang S-F, Chen K-H, Chen M, Li W-Y, Chen Y-J, Tsao C-H, Yen M, Huang JC, Chen Y-MA. 2011. Human-leukocyte antigen class I Cw 1502 and Class II DR 0301 genotypes are associated with resistance to severe acute respiratory syndrome (SARS) infection. Viral Immunol. 24(5):421–26.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu L 2016. The membrane protein of severe acute respiratory syndrome coronavirus functions as a novel cytosolic pathogen-associated molecular pattern to promote beta interferon induction via a toll-like-receptor-related TRAF3-independent mechanism. MBio. 7(1). doi:https://doi.org/10.1128/mBio.01872-15
   Google Scholar
• Wei C, Ni C, Song T, Liu Y, Yang X, Zheng Z, Jia Y, Yuan Y, Guan K, Xu Y, et al. 2010. The hepatitis B virus x protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J Immunol. 185(2):1158–68.
   PubMed Web of Science ®Google Scholar
• Wherry EJ, Kurachi M. 2015. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 15(8):486–99.
   PubMed Web of Science ®Google Scholar
• Wiener RS, Cao YX, Hinds A, Ramirez MI, Williams MC. 2007. Angiotensin converting enzyme 2 is primarily epithelial and is developmentally regulated in the mouse lung. J Cell Biochem. 101(5):1278–91.
   PubMed Web of Science ®Google Scholar
• Woodland DL. 2018. Facets of innate immunity to viral infection. Viral Immunol. 31(9):595–595.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2020. Laboratory testing of human suspected cases of novel coronavirus (‎‎‎ nCoV)‎‎‎ infection: interim guidance, 10 January 2020 (No. WHO/2019-nCoV/laboratory/2020.1).
   Google Scholar
• Wu K, Li W, Peng G, Li F. 2009. Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor. Proc Natl Acad Sci. 106(47):19970–74.
   PubMed Web of Science ®Google Scholar
• Xia Y, Jin R, Zhao J, Li W, Shen H. 2020. Risk of COVID-19 for patients with cancer. Lancet Oncol. 21(4):e180.
   PubMedGoogle Scholar
• Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, Zhong W, Hao P. 2020a. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 63(3):457–60.
   PubMed Web of Science ®Google Scholar
• Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, et al. 2020b. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 8(4):420–22.
   PubMed Web of Science ®Google Scholar
• Yang Y, Shen C, Li J, Yuan J, Wei J, Huang F, Wang F, Li G, Li Y, Xing L, et al. 2020. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. J Allergy Clin Immunol. 146(1):119–127.e4.
   PubMed Web of Science ®Google Scholar
• Yang Z, Kong W, Huang Y, Roberts A, Murphy BR, Subbarao K, Nabel GJ. 2004. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature. 428(6982):561–64.
   PubMed Web of Science ®Google Scholar
• Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. 2012. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 367(19):1814–20.
   PubMed Web of Science ®Google Scholar
• Zalinger ZB, Elliott R, Rose KM, Weiss SR. 2015. MDA5 is critical to host defense during infection with murine coronavirus. J Virol. 89(24):12330–40.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Bi J, Zheng X, Chen Y, Wang H, Wu W, Wang Z, Wu Q, Peng H, Wei H, et al. 2018. Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity. Nat Immunol. 19(7):723–32.
   PubMed Web of Science ®Google Scholar
• Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, Xu Y, Tian Z. 2020. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 17(5):533–35.
   PubMed Web of Science ®Google Scholar
• Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, Si H-R, Zhu Y, Li B, Huang C-L, et al. 2020. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 579(7798):270–73.
   PubMed Web of Science ®Google Scholar